A biotech firm formerly run by Martin Shkreli has entered Chapter 11 protection in the wake of the infamous entrepreneur’s Dec. 17 arrest on criminal securities fraud charges. The company, KaloBios Pharmaceuticals Inc., has hired Hogan Lovells as its outside bankruptcy counsel.
KaloBios’ bankruptcy petition, filed late Tuesday, comes less than two weeks after Shkreli was indicted for allegedly defrauding another pharmaceutical company he ran, and for deceiving investors in two hedge funds he managed. His lawyer, Kaye Scholer partner Evan Greebel, was also arrested and accused of conspiring with Shkreli to commit wire fraud. Both have pleaded not guilty. The U.S. Securities and Exchange Commission is also pursuing related civil charges against both men.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
